Mineralys Therapeutics Statistics
NASDAQ: MLYSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
22.09+0.14 (+0.64%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 21.80 -1.31%
Mineralys Therapeutics by the numbers
Mineralys Therapeutics has a market capitalization of $1.95 billion based on 88.41M shares outstanding. With trailing EPS of $-4.22, Mineralys Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.9% below its 50-day average and 21.7% below its 200-day average.
Average daily trading volume is 1.03M shares, or about $22.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MLYS valuation vs. peer median
| Metric | MLYS | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.95B | $1.90B | +3% |
| Avg. volume | 1.03M | 892.33K | +15% |
Peer median across 8 companies: LKFT, ZYME, GPCR, AGIO, URGN, PVLA, TRVI, PRGO.
Valuation
- Market cap
- $1.95B
- EPS (TTM)
- $-4.22
- Shares outstanding
- 88.41M
Price and trading
- Previous close
- 21.95
- Open
- 21.79
- Day range
- 21.50 – 22.44
- 52-week range
- 21.49 – 47.65
- 52-week change
- -41.34%
- Beta
- —
- Volume
- 989.01K
- Average volume
- 1.03M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2026
Additional statistics
- Market Cap
- 1.95B
- Forward Pe
- -8.84
- Eps
- -4.22
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 47.65
- Week52 Low
- 21.49
- Avg Volume
- 1.03M
- Shares Outstanding
- 88.41M
- Ma50
- 26.59
- Ma200
- 28.21
- Earnings Date
- Aug 11, 2026
- Pct From52w High
- -53.64%
- Pct From52w Low
- 2.82%